Killing pain, not neurons [2]

Nature Medicine

Volumn 11, Issue 8, 2005, Pages 817-818

  Sahagan, Barbara G ^a   Stephenson, Diane T ^b   Hounslow, Neil ^c   Liston, Dane R ^a   Manning, Pamela T ^d  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^b Groton/New London Labs   (United Kingdom)

^c Clinical Development   (United Kingdom)

^d Discovery Biology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; CELECOXIB;

ALZHEIMER DISEASE; AMYLOIDOSIS; CEREBROSPINAL FLUID ANALYSIS; DISEASE MODEL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG MEGADOSE; EVALUATION; GENE OVEREXPRESSION; HUMAN; LETTER; OSTEOARTHRITIS; PAIN; PRESCRIPTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; WILD TYPE;

EID: 23844462455     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0805-817b     Document Type: Letter

References (9)

1. Kukar, T. et al. Nat. Med. 11, 545-550 (2005).
2. Jhee, S.S. Reg. Affairs 21, 49-66 (2004).
3. Clemett, D. & Goa, K.L. Drugs 59, 957-980 (2000).
4. Sainati, S.M., Ingram, D., Talwalker, S. & Gels, G. in 6th International Stockholm-Springfield Symposium of Advances in Alzheimer's Therapy 180 (Stockholm, 2000).
5. Dembo, G., Park, S.B. & Kharasch, E.D. Anesthesiology 102, 409-415 (2005).
6. Yokota, O. et al. Prog. Neuropsychopharm. Biol. Psychiatry 26, 715-721 (2004).
7. Xiang, Z, L. et al. Gene Expr. 10, 271-278 (2002).
8. Jantzen, P.T. et al. J. Neurosci. 22, 2246-2254 (2002).
9. Aisen, P.S. et al. JAMA 289, 2819-2826 (2003).